The Week

L’Oréal S.A. (LRLCY) fell 1.32% this week to close at $88.96, lagging the S&P 500 by about 1.41 percentage points. It was a choppy week: Monday opened at $90.44, hit a weekly high of $90.51, and closed at $89.17; Tuesday dropped to $87.49; Wednesday recovered to $89.20; Thursday marked the weekly low of $87.17; Friday closed at $88.96 after a push to $89.26 failed to hold. Weekly amplitude was 3.69%, and average daily volume was about 14.44% below the 60-day median, suggesting lighter activity.

Key Events

The week’s news was centred on sell-side views and brand-asset moves. On Monday, Erste Group Bank forecast stronger earnings for L’Oréal. On Wednesday, J.P. Morgan initiated a Hold rating, and L’Oréal reported 532,649,823 shares and corresponding voting rights outstanding as of 31 August 2026. Friday brought a cluster of Armani-related headlines: L’Oréal’s Healthy Minds project is set to expand workforce mental-health evidence with Harvard Business School researchers; separately, media reported Armani faces an ‘inevitable evolution’ one year after its founder’s death, with EssilorLuxottica SA eyeing a stake in Armani beauty and voting rights capped at 31%. No company earnings were released this week, and the news had limited direct impact on the share price.

Analyst Ratings

Of four covering institutions, three rate the stock Buy and one Overweight, with no Hold, Underweight or Sell ratings. The consensus rating is Strong Buy, and the consensus target is $103.07, about 15.86% above spot. Target prices range from $100.00 to $107.00, indicating a narrow spread. Within 33 companies in the personal-care products industry, L’Oréal ranks 14th.

The Week Ahead

No L’Oréal earnings are due next week, but the macro calendar is busy. Tuesday features US NFIB small-business optimism; Thursday includes the 10-year Treasury auction, initial jobless claims, final-demand PPI, existing-home sales, wholesale sales and EIA natural-gas storage. These prints may shape near-term growth and rate expectations, with potential spillover into consumer-staples sentiment.

In Short

L’Oréal drifted lower this week, while the analyst picture stayed favourable: three Buy and one Overweight out of four, with a consensus target about 15.86% above spot. Valuation remains elevated at roughly 32.35x P/E and 6.12x P/B, and the latest daily capital-flow snapshot offers no direction signal. The book to watch is next week’s US macro data and any further development on the Armani beauty stake.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.